Comparative study to evaluate the efficacy of Mahamasha Taila Nasya with Trayodashanga Guggulu in Avabahuka.
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 72
- 试验地点
- 1
- 主要终点
- To assess the reduction in SPADI Score.
研究概览
简要总结
The study is a open label parallel group trial comparing the efficacy of Mahamasha Taila Nasya with Trayodashang Guggulu in Avabahuka. in one group Mahamasha Taila Nasya in the dose of 4 ml each nostril daily for two sessions of Nasya each comprising for seven days with the rest period of seven days in between two sessions, will be given. in another group Trayodshang Guggulu with Ushnodaka in dose of 3 gm in daily divided dose will be given. The trail will be conducted in Ch Brahm Prakash Ayurved Charak Sansthan India with primary outcome of improvement in SPADI score and secondary outcome of improvement in Bahupraspandita Hara (limited range of motion of the shoulder joint) and Amsa Shula (pain in shoulder joint).
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients having the sign and symptoms of Avabahuka as Bahupraspanditahara (limited range of motion of the upper limb) and Amsa Shoola (pain in shoulder region), for more than one month and Patients fit for Nasya karma as per the text (Charaka Samhita Sidhi Sthana 2/22).
排除标准
- •Patients of shoulder joint dislocation/fracture or has the history for the same, Pregnant women and lactating mothers, Patients suffering from major systemic disorders eg IHD, RA, Gout, SLE and Malignant and Immuno-compromised patients (AIDS).
- •Patients unfit for Nasya as with any anatomical deformity of the nasal passage e.g. cleft palate.
- •Patients with uncontrolled Diabetes Mellitus.
结局指标
主要结局
To assess the reduction in SPADI Score.
时间窗: 28 days
次要结局
- to assess the reduction in gradings of Bahupraspanditahara (limited range of motion of shoulder joint)and amsa shula (pain in shoulder region)(28 days)